Literature DB >> 19635828

Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7.

Jai J Tree1, Dai Wang, Carol McInally, Arvind Mahajan, Abigail Layton, Irene Houghton, Mikael Elofsson, Mark P Stevens, David L Gally, Andrew J Roe.   

Abstract

Recent work has highlighted a number of compounds that target bacterial virulence by affecting gene regulation. In this work, we show that small-molecule inhibitors affect the expression of the type III secretion system (T3SS) of Escherichia coli O157:H7 in liquid culture and when this bacterium is attached to bovine epithelial cells. Inhibition of T3SS expression resulted in a reduction in the capacity of the bacteria to form attaching and effacing lesions. Our results show that there is marked variation in the abilities of four structurally related compounds to inhibit the T3SS of a panel of isolates. Using transcriptomics, we performed a comprehensive analysis of the conserved and inhibitor-specific transcriptional responses to these four compounds. These analyses of gene expression show that numerous virulence genes, located on horizontally acquired DNA elements, are affected by the compounds, but the number of genes significantly affected varied markedly for the different compounds. Overall, we highlight the importance of assessing the effect of such "antivirulence" agents on a range of isolates and discuss the possible mechanisms which may lead to the coordinate downregulation of horizontally acquired virulence genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635828      PMCID: PMC2747932          DOI: 10.1128/IAI.00562-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  H-NS: a universal regulator for a dynamic genome.

Authors:  Charles J Dorman
Journal:  Nat Rev Microbiol       Date:  2004-05       Impact factor: 60.633

2.  pH regulates genes for flagellar motility, catabolism, and oxidative stress in Escherichia coli K-12.

Authors:  Lisa M Maurer; Elizabeth Yohannes; Sandra S Bondurant; Michael Radmacher; Joan L Slonczewski
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

3.  Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle.

Authors:  Leslie Bailey; Asa Gylfe; Charlotta Sundin; Sandra Muschiol; Mikael Elofsson; Peter Nordström; Birgitta Henriques-Normark; Raimond Lugert; Anders Waldenström; Hans Wolf-Watz; Sven Bergström
Journal:  FEBS Lett       Date:  2007-01-17       Impact factor: 4.124

Review 4.  Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation.

Authors:  Jay L Mellies; Alex M S Barron; Anna M Carmona
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

5.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells.

Authors:  Jorge A Girón; Alfredo G Torres; Enrique Freer; James B Kaper
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

Review 8.  Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7.

Authors:  Kenneth G Campellone; John M Leong
Journal:  Curr Opin Microbiol       Date:  2003-02       Impact factor: 7.934

9.  The LEE1 promoters from both enteropathogenic and enterohemorrhagic Escherichia coli can be activated by PerC-like proteins from either organism.

Authors:  Megan E Porter; Paul Mitchell; Andrew Free; David G E Smith; David L Gally
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

10.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.

Authors:  T K McDaniel; K G Jarvis; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more
  29 in total

1.  Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Jai J Tree; Andrew J Roe; Allen Flockhart; Sean P McAteer; Xuefang Xu; Darren Shaw; Arvind Mahajan; Scott A Beatson; Angus Best; Sabrina Lotz; Martin J Woodward; Roberto La Ragione; Kenan C Murphy; John M Leong; David L Gally
Journal:  Mol Microbiol       Date:  2011-04-15       Impact factor: 3.501

2.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

Review 3.  Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Authors:  Miles C Duncan; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

Review 4.  On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.

Authors:  Bronwyn J E Lyons; Natalie C J Strynadka
Journal:  Medchemcomm       Date:  2019-06-20       Impact factor: 3.597

5.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

6.  The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.

Authors:  Pia Uusitalo; Ulrik Hägglund; Elin Rhöös; Henrik Scherman Norberg; Mikael Elofsson; Charlotta Sundin
Journal:  J Antibiot (Tokyo)       Date:  2017-06-07       Impact factor: 2.649

7.  Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.

Authors:  Jianfang Li; Chao Lv; Weiyang Sun; Zhenyu Li; Xiaowei Han; Yaoyao Li; Yuemao Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 8.  Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target.

Authors:  Alyssa C Fasciano; Lamyaa Shaban; Joan Mecsas
Journal:  EcoSal Plus       Date:  2019-02

9.  Small molecules aimed at type III secretion systems to inhibit bacterial virulence.

Authors:  Lun K Tsou; Paul D Dossa; Howard C Hang
Journal:  Medchemcomm       Date:  2013-01-01       Impact factor: 3.597

10.  Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.

Authors:  Hanh N Lam; Tannia Lau; Adam Lentz; Jessica Sherry; Alejandro Cabrera-Cortez; Karen Hug; Annalyse Lalljie; Joanne Engel; R Scott Lokey; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.